Skip to main content

Advertising Disclaimer »

Main menu

  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • Authors/Reviewers
    • Submit Manuscript
    • Author Guidelines
    • Reviewer Guidelines
    • Open Access
    • Editorial Policies
  • Content
    • Current Issue
    • Online First
    • Archive
    • Blogs
    • Topic/Program Collections
    • AAP Meeting Abstracts
  • Pediatric Collections
    • COVID-19
    • Racism and Its Effects on Pediatric Health
    • More Collections...
  • AAP Policy
  • Supplements
  • Multimedia
    • Video Abstracts
    • Pediatrics On Call Podcast
  • Subscribe
  • Alerts
  • Careers
  • Other Publications
    • American Academy of Pediatrics

User menu

  • Log in
  • My Cart

Search

  • Advanced search
American Academy of Pediatrics

AAP Gateway

Advanced Search

AAP Logo

  • Log in
  • My Cart
  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • Authors/Reviewers
    • Submit Manuscript
    • Author Guidelines
    • Reviewer Guidelines
    • Open Access
    • Editorial Policies
  • Content
    • Current Issue
    • Online First
    • Archive
    • Blogs
    • Topic/Program Collections
    • AAP Meeting Abstracts
  • Pediatric Collections
    • COVID-19
    • Racism and Its Effects on Pediatric Health
    • More Collections...
  • AAP Policy
  • Supplements
  • Multimedia
    • Video Abstracts
    • Pediatrics On Call Podcast
  • Subscribe
  • Alerts
  • Careers

Discover Pediatric Collections on COVID-19 and Racism and Its Effects on Pediatric Health

American Academy of Pediatrics

revised

  • 94(4):558
AMERICAN ACADEMY OF PEDIATRICS

Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation

; Subcommittee on Hyperbilirubinemia
Pediatrics July 2004, 114 (1) 297-316; DOI: https://doi.org/10.1542/peds.114.1.297
  • Article
  • Figures & Data
  • Info & Metrics
  • Comments
Loading

Article Information

vol. 114 no. 1 297-316
DOI 
https://doi.org/10.1542/peds.114.1.297
PubMed 
15231951

Published By 
American Academy of Pediatrics
Print ISSN 
0031-4005
Online ISSN 
1098-4275
History 
  • Published online July 1, 2004.

Copyright & Usage 
Copyright © 2004 by the American Academy of Pediatrics

Author Information

  1. Subcommittee on Hyperbilirubinemia
View Full Text

Article usage

Article usage: June 2004 to January 2021

AbstractFullPdf
Jun 2004160
Jul 200482540963980
Aug 200433131492775
Sep 200438132452459
Oct 200450438672450
Nov 200446831682497
Dec 200430124521727
Jan 200532330771797
Feb 200536824471680
Mar 200534127951870
Apr 200534522611455
May 200579626551784
Jun 200570926341687
Jul 200575727771936
Aug 2005100327762121
Sep 200594328492005
Oct 200595728791995
Nov 200556628451850
Dec 200538522101380
Jan 200644518551040
Feb 200628318891056
Mar 200634618611049
Apr 20063271584809
May 20064991706945
Jun 200643614911019
Jul 200648216271029
Aug 20063821597894
Sep 20064311694926
Oct 20064941938906
Nov 20064681946994
Dec 20063251692656
Jan 20073791938784
Feb 20073871782834
Mar 20074451839914
Apr 20073801773781
May 20073251807807
Jun 20072861574823
Jul 20073702030806
Aug 20073471735880
Sep 20073581601904
Oct 20074141869913
Nov 200739815982910
Dec 20073501010619
Jan 20082851300703
Feb 20083211421805
Mar 20083241740860
Apr 20083011651834
May 20083151520813
Jun 20082991567744
Jul 20083711792863
Aug 20083701746885
Sep 20084461804894
Oct 20084121794868
Nov 20083921853787
Dec 20083401475661
Jan 20094941904957
Feb 20096231914949
Mar 200960321231080
Apr 20095092146961
May 20095412018959
Jun 200962123601070
Jul 200991427041269
Aug 200993026601315
Sep 200980825461194
Oct 200955127291201
Nov 200945223521109
Dec 20095302074914
Jan 201086524681297
Feb 201047424521071
Mar 201053827351148
Apr 201064825631272
May 201063325361137
Jun 201056224801120
Jul 201049531081469
Aug 201046430861313
Sep 201051231451221
Oct 201048831721114
Nov 201045533461104
Dec 20104152258800
Jan 201144225981004
Feb 20114082427940
Mar 20113792473936
Apr 20112872815967
May 201161530611221
Jun 201179126691020
Jul 201172828311255
Aug 201187429591256
Sep 201192433221223
Oct 201186436671670
Nov 201161933361641
Dec 201159229741077
Jan 201283732601521
Feb 201279432581599
Mar 20122289103173110
Apr 2012266195233309
May 2012270398563172
Jun 2012190093033114
Jul 20122316103123620
Aug 2012240198733751
Sep 20122342103087790
Oct 20122265105974622
Nov 2012218293924021
Dec 2012182389923470
Jan 20132390112334328
Feb 20132160113064272
Mar 20132160120154548
Apr 20132252114694545
May 20132016111114307
Jun 20131867109014516
Jul 20132333125145166
Aug 20132167112046108
Sep 20132106113744893
Oct 20132237122455723
Nov 20131818115965762
Dec 2013143494774943
Jan 2014183396795744
Feb 2014175999375897
Mar 20141790103256533
Apr 20141675100706086
May 2014158598016244
Jun 2014159188894806
Jul 20141885109385199
Aug 2014179399544556
Sep 2014181298414794
Oct 20141643109835565
Nov 2014174594574778
Dec 2014126884263671
Jan 20151850110344800
Feb 2015168789264419
Mar 2015170693795046
Apr 2015186494444829
May 2015156787874863
Jun 2015157185854435
Jul 2015165897805089
Aug 2015160194904801
Sep 2015150295025465
Oct 20151580103345636
Nov 2015525116195003
Dec 2015450105443886
Jan 2016528114244593
Feb 2016373115454315
Mar 2016270115734420
Apr 2016232111414394
May 2016245117424117
Jun 2016200143053708
Jul 2016230146863798
Aug 2016236145564208
Sep 2016340142254421
Oct 2016296287755685
Nov 2016317217225725
Dec 2016100250454403
Jan 20171247654532
Feb 20171157304732
Mar 20176162746252
Apr 20174138484972
May 20170134694329
Jun 20178119374442
Jul 20171128214906
Aug 20179138535307
Sep 201731138735539
Oct 201738154506474
Nov 201745149585883
Dec 201765146805251
Jan 201864158635572
Feb 201882148964706
Mar 201857170215124
Apr 201855166934907
May 201850149415425
Jun 201832137434674
Jul 201842146584852
Aug 201833143895370
Sep 201829140675662
Oct 201826156156404
Nov 201811139816525
Dec 20181160586126
Jan 201973153866610
Feb 2019119120916443
Mar 2019153123597345
Apr 2019140112746694
May 2019172110876916
Jun 2019244104326867
Jul 2019236111696985
Aug 2019300108346768
Sep 201917799706141
Oct 2019147108085083
Nov 20191790594642
Dec 20192384623235
Jan 20201795083626
Feb 2020192393324
Mar 2020989583250
Apr 2020595713633
May 2020892893777
Jun 202015102393993
Jul 20201116015746
Aug 2020695513622
Sep 20202110004310
Oct 20201109884219
Nov 20205101143647
Dec 2020698933303
Jan 20211108453691

Cited By...

  • 1224 Citations
  • Google Scholar
PreviousNext
Back to top

Advertising Disclaimer »

In this issue

Pediatrics
Vol. 114, Issue 1
1 Jul 2004
  • Table of Contents
  • Index by author
View this article with LENS
PreviousNext
Email Article

Thank you for your interest in spreading the word on American Academy of Pediatrics.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation
(Your Name) has sent you a message from American Academy of Pediatrics
(Your Name) thought you would like to see the American Academy of Pediatrics web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Request Permissions
Article Alerts
Log in
You will be redirected to aap.org to login or to create your account.
Or Sign In to Email Alerts with your Email Address
Citation Tools
Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation
Pediatrics Jul 2004, 114 (1) 297-316; DOI: 10.1542/peds.114.1.297

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation
Pediatrics Jul 2004, 114 (1) 297-316; DOI: 10.1542/peds.114.1.297
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Print
Download PDF
Insight Alerts
  • Table of Contents

Jump to section

  • Article
    • Abstract
    • BACKGROUND
    • DEFINITION OF RECOMMENDATIONS
    • BILIRUBIN ENCEPHALOPATHY AND KERNICTERUS
    • FOCUS OF GUIDELINE
    • PRIMARY PREVENTION
    • SECONDARY PREVENTION
    • TREATMENT
    • IMPLEMENTATION STRATEGIES
    • FUTURE RESEARCH
    • CONCLUSIONS
    • APPENDIX 1: Additional Notes
    • APPENDIX 2: Phototherapy
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • Comments

Related Articles

  • ERRATUM
  • PubMed
  • Google Scholar

Cited By...

  • Systematic review of global clinical practice guidelines for neonatal hyperbilirubinemia
  • Small-Area Variation in the Care of Low-Risk Neonates in Massachusetts and Texas
  • Neonatal Indirect Hyperbilirubinemia
  • Is it safe to use visible blue light-emitting diode phototherapy for neonatal jaundice in infants who are also treated with amiodarone?
  • Variation in Care and Clinical Outcomes Among Infants Hospitalized With Hyperbilirubinemia
  • Case 1: Rapidly Rising Bilirubin Level in a 3-day-old Term Infant
  • Determinants of neonatal jaundice among neonates admitted to five referral hospitals in Amhara region, Northern Ethiopia: an unmatched case-control study
  • Glucose-6-Phosphate Dehydrogenase Deficiency and the Benefits of Early Screening
  • Approach to red blood cell antibody testing during pregnancy: Answers to commonly asked questions
  • Supporting Breastfeeding in Infants Hospitalized for Jaundice
  • Extreme neonatal hyperbilirubinaemia in refugee and migrant populations: retrospective cohort
  • Pathogenesis and Management of Indirect Hyperbilirubinemia in Preterm Neonates Less Than 35 Weeks: Moving Toward a Standardized Approach
  • Providing Care for Infants Born at Home
  • Evidence-Based Updates on the First Week of Exclusive Breastfeeding Among Infants >=35 Weeks
  • Prevalence of and mothers knowledge, attitude and practice towards glucose-6-phosphate dehydrogenase deficiency among neonates with jaundice: a cross-sectional study
  • Prediction of Rebound Hyperbilirubinemia
  • Legal Briefs: Multiple Missteps and System Failures Cause Kernicterus in 2 Infants
  • Case 1: Severe Jaundice in a 2-day-old Term Neonate
  • Potential protective effects of bilirubin following the treatment of neonatal hypoxic-ischemic encephalopathy with hypothermia therapy
  • A Novel Icterometer for Hyperbilirubinemia Screening in Low-Resource Settings
  • Congenital Syphilis: A Challenging Case for NICU Clinicians
  • Screening and treatment to reduce severe hyperbilirubinaemia in infants in primary care (STARSHIP): a factorial stepped-wedge cluster randomised controlled trial protocol
  • Phototherapy for Neonatal Unconjugated Hyperbilirubinemia: Examining Outcomes by Level of Care
  • Exposure to Phototherapy and Childhood Seizure Risk
  • Wireless, battery-free, flexible, miniaturized dosimeters monitor exposure to solar radiation and to light for phototherapy
  • The Snowball Effect of Low-Value Care
  • How to evaluate diagnosis and management of biliary atresia in the era of liver Transplantation in China
  • Adherence to AAP Healthy Newborn Discharge Criteria in a Tertiary Care Childrens Hospital
  • Hyperbilirubinemia, Phototherapy, and Childhood Asthma
  • Outcomes of neonatal jaundice in Taiwan
  • Childhood Seizures After Phototherapy
  • Phototherapy and Seizures: Should We Change Practice?
  • Beyond "Asian": Specific East and Southeast Asian Races or Ethnicities Associated With Jaundice Readmission
  • Neonatal Jaundice: Improved Quality and Cost Savings After Implementation of a Standard Pathway
  • Neonatal Hyperbilirubinemia and Chronic Auditory Toxicity
  • Burden of severe neonatal jaundice: a systematic review and meta-analysis
  • Jaundice: Newborn to Age 2 Months
  • Chronic Auditory Toxicity in Late Preterm and Term Infants With Significant Hyperbilirubinemia
  • Use of a Smartphone App to Assess Neonatal Jaundice
  • Re: Changs Score Is Only Helpful Within the First 4 to 5 Days of Life
  • Current Scope of Practice for Newborn Care in Non-Intensive Hospital Settings
  • A Clinical Prediction Rule for Rebound Hyperbilirubinemia Following Inpatient Phototherapy
  • We Can Teach How to Bend the Cost Curve: Lessons in Pediatric High-Value Health Care
  • Can I Stop Phototherapy for This Baby?
  • Update on Pediatric Overuse
  • Transcutaneous Bilirubinometry in Jaundiced Neonates: A Randomized Controlled Trial
  • Hereditary Spherocytosis
  • Phototherapy and Risk of Type 1 Diabetes
  • The Bilirubin Binding Panel: A Henderson-Hasselbalch Approach to Neonatal Hyperbilirubinemia
  • Differences Between Transcutaneous and Serum Bilirubin Measurements in Black African Neonates
  • Battery-free, stretchable optoelectronic systems for wireless optical characterization of the skin
  • Evaluating Nursery Phototherapy Use and Discharge Practices After the Creation of a Weekend Newborn Clinic
  • Retrospective Cohort Study of Phototherapy and Childhood Cancer in Northern California
  • Neonatal Phototherapy and Infantile Cancer
  • Utility of Decision Rules for Transcutaneous Bilirubin Measurements
  • When Intensive Care Is Too Intense: Variations in Standard Practices Across Hospital Acuity Levels
  • Benefits of Delayed Cord Clamping in Red Blood Cell Alloimmunization
  • The Blockade of NF-{kappa}B Activation by a Specific Inhibitory Peptide Has a Strong Neuroprotective Role in a Sprague-Dawley Rat Kernicterus Model
  • Predicting Nonhemolytic Neonatal Hyperbilirubinemia
  • Topics in Neonatal Informatics: Essential Functionalities of the Neonatal Electronic Health Record
  • Hemolytic disease of the fetus and newborn: managing the mother, fetus, and newborn
  • A Model for Predicting Significant Hyperbilirubinemia in Neonates From China
  • Risk of Sensorineural Hearing Loss and Bilirubin Exchange Transfusion Thresholds
  • How to use: the direct antiglobulin test in newborns
  • A Pediatrician's Practical Guide to Diagnosing and Treating Hereditary Spherocytosis in Neonates
  • Medical Evaluation of Abandoned Infants Less Than 61 Days of Age
  • Early Weight Loss Nomograms for Formula Fed Newborns
  • Hospital Stay for Healthy Term Newborn Infants
  • Google Scholar

More in this TOC Section

  • Exposure to Nontraditional Pets at Home and to Animals in Public Settings: Risks to Children
  • Medical Emergencies Occurring at School
  • Disaster Planning for Schools
Show more AMERICAN ACADEMY OF PEDIATRICS

Similar Articles

Subjects

  • Nephrology
    • Nephrology
  • AAP Policy Collections by Authoring Entities
    • Steering Committee on Quality Improvement and Management
    • Subcommittee on Hyperbilirubinemia
  • Current Policy
  • Fetus/Newborn Infant
    • Fetus/Newborn Infant
    • Hyperbilirubinemia
  • Journal Info
  • Editorial Board
  • Editorial Policies
  • Overview
  • Licensing Information
  • Authors/Reviewers
  • Author Guidelines
  • Submit My Manuscript
  • Open Access
  • Reviewer Guidelines
  • Librarians
  • Institutional Subscriptions
  • Usage Stats
  • Support
  • Contact Us
  • Subscribe
  • Resources
  • Media Kit
  • About
  • International Access
  • Terms of Use
  • Privacy Statement
  • FAQ
  • AAP.org
  • shopAAP
  • Follow American Academy of Pediatrics on Instagram
  • Visit American Academy of Pediatrics on Facebook
  • Follow American Academy of Pediatrics on Twitter
  • Follow American Academy of Pediatrics on Youtube
  • RSS
American Academy of Pediatrics

© 2021 American Academy of Pediatrics